Ironwood reiterates 2026 LINZESS guidance of $1.125B-$1.175B as STARS-2 initiation nears
Ironwood Pharmaceuticals, Inc. - Class A · PHARMACEUTICAL PREPARATIONS · Now $3.46
-13% in 7d after detection
Post-detection moves
1h
—
1d
-1.2%
3d
-13%
7d
-13%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS